Data as of 4:00pm ET
| +0.019 / +4.03%|
The 1 analysts offering 12-month price forecasts for Acura Pharmaceuticals Inc have a median target of 1.50, with a high estimate of 1.50 and a low estimate of 1.50. The median estimate represents a +206.12% increase from the last price of 0.49.
The current consensus among 1 polled investment analysts is to Buy stock in Acura Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.